Navigating Challenges In Immune Cell Therapy Analysis

During this panel, experts discuss the challenges faced by developers and manufacturers in the immune cell therapy field. These challenges include scalability, regulatory hurdles, and data standardization. The panelists explore the impact of automation in addressing these challenges and the rise of closed-system cell manufacturing platforms as an emerging trend in the field. They also discuss the potential expansion of immune cell therapy beyond blood cancers and the use of viral and non-viral methods for gene editing.